| Literature DB >> 28781125 |
Virginia J Bruce1, Brian R McNaughton2.
Abstract
Currently, 7 of the top 10 selling drugs are biologics, and all of them are proteins. Their large size, structural complexity, and molecular diversity often results in surfaces capable of potent and selective recognition of receptors that challenge, or evade, traditional small molecules. However, most proteins do not penetrate the lipid bilayer exterior of mammalian cells. This severe limitation dramatically limits the number of disease-relevant receptors that proteins can target and modulate. Given the major role proteins play in modern medicine, and the magnitude of this limitation, it is unsurprising that an enormous amount of effort has been dedicated to overcoming this pesky impediment. In this article, we summarize and evaluate current approaches for intracellular delivery of exogenous proteins to mammalian cells and, in doing so, aim to illuminate fertile ground for future discovery in this critical area of research.Entities:
Keywords: CRISPR; cell-penetrating peptide; lipid-cation; protein delivery; protein resurfacing; viral vector
Mesh:
Substances:
Year: 2017 PMID: 28781125 DOI: 10.1016/j.chembiol.2017.06.014
Source DB: PubMed Journal: Cell Chem Biol ISSN: 2451-9448 Impact factor: 8.116